article Open Access
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
European Journal of Cancer · 2005 · Vol. 41(8) · pp. 1135–1139
Tjeerd J. Postma✉(Amsterdam UMC Location VUmc)Neil K. Aaronson(The Netherlands Cancer Institute)Jan J. Heimans(Amsterdam UMC Location VUmc)Mirte Muller(The Netherlands Cancer Institute)Jerzy Hildebrand(Erasmus Hospital)J.‐Y. Delattre(Pitié-Salpêtrière Hospital)Khê Hoang‐Xuan(Pitié-Salpêtrière Hospital)Michel Lantéri‐Minet(Hôpital Pasteur)Robin Grant(Western General Hospital)Robert Huddart(Royal Marsden Hospital)Clare Moynihan(Royal Marsden NHS Foundation Trust)JaneMaree Maher(Mount Vernon Hospital)R. Lucey(Mount Vernon Hospital)
Cancer Treatment and PharmacologyChemotherapy-related skin toxicityGlioma Diagnosis and TreatmentChemotherapy-induced peripheral neuropathyMedicineQuality of life (healthcare)Grading (engineering)Peripheral neuropathyClinical trialCancerIntensive care medicinePhysical therapyOncology
MeSH terms
AdultAgedAntineoplastic AgentsFemaleHumansMaleMiddle AgedNeoplasmsPeripheral Nervous System DiseasesQuality of LifeSurveys and Questionnaires
Citations
568
FWCI
1.16
field-weighted impact
References
20
Percentile
78%
vs. same field & year
Citations per year
References
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
Journal of Clinical Oncology · 1993 · 5,962 citations
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
JNCI Journal of the National Cancer Institute · 1993 · 15,705 citations
Reporting results of cancer treatment
Cancer · 1981 · 7,848 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.